Multiple Myeloma Stem Cell Transplant Survival Rate

Autologous stem cell transplantation autosct has an important role in the treatment of patients with symptomatic multiple myeloma mm.

Multiple myeloma stem cell transplant survival rate.

The high doses of chemo or radiation used to treat a multiple myeloma relapse can kill the stem cells in your bone marrow. The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival. A population based study published correction appears in blood. A relative survival rate compares people with the same type and stage of cancer to people in the overall population.

To protect them your doctor removes stem cells. We here analyze factors influencing survival in 865 newly diagnosed mm patien. The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports. Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body.

Treatment options for myeloma have expanded in. In some cases a bone marrow or stem cell transplant is an option. All things considered while the autologous transplant can make the myeloma go away for a period of time even years it does not cure the growth and inevitably the myeloma back. Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said.

There can be a long period of dormancy that could. Multiple myeloma isn t considered curable but symptoms wax and wane. Findings from a phase 3 clinical trial note that patients with multiple myeloma who receive upfront autologous stem cell transplant asct typically live longer without disease. See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic.

Patients with multiple myeloma live longer without their disease progressing if they get a stem cell transplant compared with patients who received chemotherapy alone. Stem cell transplant is commonly used to treat multiple myeloma. For example if the 5 year relative survival rate for a specific stage of multiple myeloma is 60 it means that people who have that cancer are on average about 60 as likely as people who don t have that cancer to live for.